1. Metabolic Reprogramming of the Right Ventricle and Pulmonary Arteries in a Flow-Associated Pulmonary Arterial Hypertension Rat Model
   Dongli Liu et al, 2022, ACS Omega CrossRef
2. Long-Term Cardiac Damage Associated With Abdominal Irradiation in Mice
   Zhaojia Wang et al, 2022, Frontiers in Pharmacology CrossRef
3. Metabolomics in Pulmonary Hypertension—A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology
   Pier Paolo Bassareo et al, 2023, International Journal of Molecular Sciences CrossRef
4. The effect of rehabilitation exercise on the expression of glutaminase and cardiopulmonary remodeling in pulmonary hypertension
   Shang Wang et al, 2022, Medicine in Novel Technology and Devices CrossRef
5. NMR-Based Metabolomic Analysis of Plasma in Patients with Adult Congenital Heart Disease and Associated Pulmonary Arterial Hypertension: A Pilot Study
   Beizhu Xu et al, 2022, Metabolites CrossRef
6. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
   Daniel Morales-Cano et al, 2023, Frontiers in Pharmacology CrossRef
7. Skeletal and cardiac muscle have different protein turnover responses in a model of right heart failure
   Danielle R. Bruns et al, 2023, GeroScience CrossRef
8. Branched-chain amino acids govern the high learning ability phenotype in Tokai high avoider (THA) rats
   Yukari Shida et al, 2021, Scientific Reports CrossRef
9. Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension
   Daniel Colon Hidalgo et al, 2022, Antioxidants CrossRef
10. Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction
    Federico Ferro et al, 2022, Biomolecules CrossRef